Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy
Lin Tian, Anhua Lei, Tianyu Tan, et al.
Kidney Diseases (2021) Vol. 8, Iss. 1, pp. 26-43
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials
Wenru Zhang, Mengmeng Wang, Chonghao Ji, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116930-116930
Open Access | Times Cited: 27
Advancements of Prussian blue-based nanoplatforms in biomedical fields: Progress and perspectives
Yanhui Wang, Zonghao Liang, Ziyang Liang, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 752-778
Closed Access | Times Cited: 43
Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance
Shivani Yadav, Astik Priya, Diksha R. Borade, et al.
Immunologic Research (2022) Vol. 71, Iss. 2, pp. 130-152
Open Access | Times Cited: 34
Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)
Jingquan Huang, Qiulin Wu, David A. Geller, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy
Paulina Czajka‐Francuz, Maria J. Prendes, Arun K. Mankan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Harnessing the potential of CD40 agonism in cancer therapy
Yang Zhou, Ann Richmond, Chi Yan
Cytokine & Growth Factor Reviews (2023) Vol. 75, pp. 40-56
Open Access | Times Cited: 16
New hope for tumor immunotherapy: the macrophage-related “do not eat me” signaling pathway
Han Deng, Guan Wang, Shengyan Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer
Won Chan Hwang, Doona Song, Hyesung Lee, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 9, pp. 1563-1576
Open Access | Times Cited: 20
Roles of exosomes as drug delivery systems in cancer immunotherapy: a mini-review
Zhen Fang, Yixuan Ding, Zhigang Xue, et al.
Discover Oncology (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Targeting the depletion of M2 macrophages: implication in cancer immunotherapy
Talia Festekdjian, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 55-73
Closed Access | Times Cited: 4
Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment
Mahmoud Singer, Zhuoli Zhang, Farshid Dayyani, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 66-66
Open Access | Times Cited: 3
Obesity and Fibrosis: Setting the Stage for Breast Cancer
Genevra Kuziel, Brittney N. Moore, Lisa M. Arendt
Cancers (2023) Vol. 15, Iss. 11, pp. 2929-2929
Open Access | Times Cited: 8
IL9 Polarizes Macrophages to M1 and Induces the Infiltration of Antitumor Immune Cells via MIP-1 and CXCR3 Chemokines
Van Anh Do-Thi, Sang Min Park, Song Mi Park, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 1, pp. 80-96
Open Access | Times Cited: 7
Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy
Gayatri Reghu, Praveen Kumar Vemula, Sarita G. Bhat, et al.
Journal of Biosciences (2024) Vol. 49, Iss. 2
Open Access | Times Cited: 2
Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?
Chilam Chan, Marta Lustig, Niklas Baumann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma
Xiaodong Geng, Kun Chi, Chao Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics
Maryam Sayahinouri, Sahar Mashayekhi Firouz, Amin Ebrahimi Sadrabadi, et al.
Bioimpacts (2023)
Open Access | Times Cited: 5
Sophisticated genetically engineered macrophages, CAR-Macs, in hitting the bull’s eye for solid cancer immunotherapy approaches
Neşe Ünver
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3171-3177
Closed Access | Times Cited: 5
COL10A1 as a Prognostic Biomarker in Association with Immune Infiltration in Prostate Cancer
Chenyang Wang, Jirong Wang, Siyu Chen, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 340-353
Closed Access | Times Cited: 5
C-Myc-induced hypersialylation of small cell lung cancer facilitates pro-tumoral phenotypes of macrophages
Lin Tian, Hui Li, Peiyan Zhao, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107771-107771
Open Access | Times Cited: 5
In vitro Studies on Anticoccidial Effects of Healthy Sheep Bile against Eimeria magna and Eimeria exigua Oocysts and Sporozoites Isolated from Domestic Rabbits
Mutee Murshed, Mohammed M. Mares, Hossam M. Aljawdah, et al.
Indian Journal of Animal Research (2024), Iss. Of
Open Access | Times Cited: 1
Therapeutic approaches of cell therapy based on stem cells and terminally differentiated cells: Potential and effectiveness
Ali Pirsadeghi, Negar Namakkoobi, Mahtab Sharifzadeh Behzadi, et al.
Cells and Development (2024) Vol. 177, pp. 203904-203904
Closed Access | Times Cited: 1
Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
Meng Lv, Yan Liu, Wei Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
Jingyang Li, Qinyun Du, Jiayi Sun, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
BIOLOGICAL REACTIONS OF MACROPHAGES TO METAL OXIDE NANOPARTICLES
Mohammed Zorah, Hassan Lafta Atiyah, NOOR WATHTHAB ALI, et al.
International Journal of Applied Pharmaceutics (2024), pp. 62-70
Open Access
Page 1 - Next Page

Scroll to top